Search
Nektar Therapeutics
NKTRAdd to Watchlist
70.670USD
-0.780-1.09%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.39BMarket Cap
LossP/E TTM
NKTR Financials
See Nektar Therapeutics's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Nektar Therapeutics Earnings Date
Latest Release
Aug 13, 2026
EPS / Forecast
--/-1.98
Revenue / Forecast
--/10.42M
Period
FY2025 Earnings
Revenue(YoY)
55.23M
-43.89%
EPS(YoY)
-9.73
-12.09%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total revenue reached 55.23M, with a year-on-year change of 98.43M.
What are the current assets of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its current assets were 266.27M, with a year-on-year change of 1.90.
What are the total assets of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total assets of Nektar Therapeutics were 280.41M, with a year-on-year change of -7.72.
What are the total liabilities of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total liabilities of Nektar Therapeutics were 190.57M, with a year-on-year change of -21.61.
What is the total equity of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total equity of Nektar Therapeutics was 89.83M, with a year-on-year change of 47.90.
What is the net operating income of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net operating income of Nektar Therapeutics was -130.77M, with a year-on-year change of -0.66.
What is the net investment of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net investment of Nektar Therapeutics was -1.20M, with a year-on-year change of -100.84.
What is the net financing of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net financing of Nektar Therapeutics was 180.57M, with a year-on-year change of 328.71.
What is the Earnings Per Share (EPS) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Earnings Per Share (EPS) was -9.73, with a year-on-year change of -12.09.
What is the net income of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net income was -164.08M, with a year-on-year change of -37.92.
What is the net margin of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net profit margin was -297.07, with a year-on-year change of -145.79.
What is the gross margin of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its gross margin was 100.00, with a year-on-year change of 45.30.
What is the debt-to-asset ratio of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its debt-to-asset ratio was 22.52, with a year-on-year change of -25.43.
What is the Return on Equity (ROE) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Return on Equity (ROE) was -217.94, with a year-on-year change of -75.62.
What is the Return on Assets (ROA) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Return on Assets (ROA) was -56.17, with a year-on-year change of -65.69.
What is the operating profit of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its operating profit was -130.77M, with a year-on-year change of -0.66.